Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)
Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)
Not yet recruiting · NCT07601295 · Registry updated 2026-05-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH) | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Not yet recruiting | Phase 2 | 2026-05-22 | NCT07601295 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 791 |
| Stanford University | 620 |
| University of Michigan | 394 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Brown University/Rhode Island Hospital | Providence | United States | 1 |
| Duke University | Durham | United States | 160 |
| Harvard University / Brigham and Women's Hospital | Boston | United States | 1 |
| Stanford University | Stanford | United States | 213 |
| The University of Arizona / Banner University Medical Center | Tucson | United States | 1 |
| University of California, San Francisco | San Francisco | United States | 294 |
| University of Colorado (UCD) Anschutz | Aurora | United States | 1 |
| University of Pennsylvania | Philadelphia | United States | 507 |
| University of Texas Southwestern | Dallas | United States | 73 |
| University of Washington | Seattle | United States | 172 |